Interferon free hepatitis C treatment regimens: The beginning of another era

Fred Poordad, Grace M. Chee

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Hepatitis C is a virus affecting millions worldwide and is a major health risk. With the potentially severe adverse event profile of the current backbone of therapy, interferon, there is an impetus to discover interferon free treatment regimens. With the development of new oral direct acting antivirals, interferon free regimens may be available in the next few years. This article discusses some of the preliminary data from interferon free studies.

Original languageEnglish (US)
Pages (from-to)74-77
Number of pages4
JournalCurrent Gastroenterology Reports
Issue number1
StatePublished - Feb 2012
Externally publishedYes


  • Direct acting antivirals
  • Hepatitis C
  • Interferon
  • Interferon free
  • Polymerase inhibitor
  • Protease inhibitor
  • Ribavirin
  • SVR

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Interferon free hepatitis C treatment regimens: The beginning of another era'. Together they form a unique fingerprint.

Cite this